Catalent | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
Agilent USD 1.49B 19M 2025-04
AstraZeneca USD 5.23B 258M 2025-03
Bristol-Myers Squibb USD 10.88B 529M 2025-03
Bruker USD 184.2M 800K 2025-03
Centene USD 14.82B 752M 2025-03
Charles River Laboratories USD 229.36M 34.75M 2025-03
Cigna USD 8.33B 784M 2025-03
Danaher USD 1.99B 85M 2025-03
Dentsply International USD 398M 126M 2025-03
Elevance Health USD 7.5B 788M 2025-03
Eli Lilly USD 3.09B 175.1M 2025-03
Glaxosmithkline GBP 3.87B 678M 2024-12
Hologic USD 1.43B 352.6M 2025-03
Humana USD 4.25B 2.03B 2025-03
Illumina USD 1.11B 14M 2025-03
Intuitive Surgical USD 9.1B 268.8M 2025-03
IQVIA Holdings USD 1.74B 38M 2025-03
J&J USD 38.47B 32.35B 2025-03
Laboratory Of America USD 369.4M 1.15B 2025-03
Lonza CHF 1.11B 286M 2024-12
McKesson USD 5.69B 4.56B 2025-03
Merck EUR 1.01B 1.14B 2025-03
Merck USD 8.63B 4.61B 2025-03
Mettler Toledo International USD 64.29M 4.93M 2025-03
Novartis USD 8.87B 4.74B 2024-12
Pfizer USD 1.43B 387M 2025-03
Quest Diagnostics USD 188M 361M 2025-03
Repligen USD 697.23M 60.13M 2025-03
Revvity USD 1.14B 25.78M 2025-03
Roche Holding CHF 6.98B 2.15B 2024-12
Supernus Pharmaceuticals USD 69.33M 37.66M 2024-12
Thermo Fisher Scientific USD 4.13B 125M 2025-03
UnitedHealth USD 34.29B 8.98B 2025-03
Waters USD 382.87M 58.45M 2025-03
West Pharmaceutical Services USD 404.2M 80.4M 2025-03


Catalent Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Jul 2025.